Emerging role of pericytes in therapy of cardiovascular diseases

Siarhei A Dabravolski1, Alexander M Markin2, Elena R Andreeva3

  • 1Department of Biotechnology Engineering, ORT Braude College, Snunit 51, P.O. Box 78, Karmiel 2161002, Israel.

Insights

Pericytes, crucial vascular cells, are key in cardiovascular disease (CVD) and emerging as a promising cell therapy. This review explores their roles in CVD and therapeutic potential.

Area of Science:

  • Cardiovascular Biology
  • Cellular Biology
  • Regenerative Medicine

Background:

  • Pericytes are mural cells integral to microvascular structure and function.
  • They play critical roles in maintaining vascular integrity, permeability, and blood flow.
  • Pericytes are increasingly recognized for their involvement in cardiovascular disease (CVD) pathogenesis.

Purpose of the Study:

  • To review current knowledge on pericyte metabolism, trans-differentiation, angiogenesis, and immunomodulation in CVD.
  • To discuss the therapeutic potential of pericytes for various cardiovascular conditions.
  • To explore pericyte-mediated pharmacological strategies for CVD treatment.

Main Methods:

  • Literature review of recent data on pericyte functions in cardiovascular pathologies.
  • Analysis of in vitro and in vivo studies on pericyte-based cell therapies.
  • Discussion of pharmacological approaches targeting pericytes.

Main Results:

  • Pericytes exhibit diverse functions including metabolism, trans-differentiation, angiogenesis, and immunomodulation relevant to CVD.
  • Pericyte transplantation shows promise in preclinical models for coronary artery disease, congenital heart disease, and valvular heart disease.
  • Pericytes represent a viable target for novel pharmacological interventions in CVD.

Conclusions:

  • Pericytes are pivotal in cardiovascular health and disease, offering significant therapeutic opportunities.
  • Cell therapy and pharmacological targeting of pericytes hold great potential for treating a range of CVDs.
  • Further research into pericyte biology and therapeutic applications is warranted for effective CVD management.